Alphasimplex Group LLC trimmed its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) by 44.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,281 shares of the medical instruments supplier’s stock after selling 2,602 shares during the quarter. Alphasimplex Group LLC’s holdings in Merit Medical Systems were worth $204,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new stake in shares of Merit Medical Systems during the 3rd quarter worth approximately $31,000. Lindbrook Capital LLC acquired a new stake in Merit Medical Systems in the 4th quarter valued at approximately $38,000. Altshuler Shaham Ltd acquired a new stake in Merit Medical Systems in the 3rd quarter valued at approximately $50,000. First Horizon Advisors Inc. increased its position in Merit Medical Systems by 23.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,032 shares of the medical instruments supplier’s stock valued at $90,000 after acquiring an additional 196 shares during the period. Finally, Marco Investment Management LLC acquired a new stake in Merit Medical Systems in the 3rd quarter valued at approximately $208,000. Institutional investors and hedge funds own 95.25% of the company’s stock.
Shares of NASDAQ MMSI traded up $1.82 during mid-day trading on Friday, reaching $58.85. The company had a trading volume of 351,305 shares, compared to its average volume of 378,758. The company has a current ratio of 2.35, a quick ratio of 1.21 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average price of $64.43 and a two-hundred day moving average price of $62.92. Merit Medical Systems, Inc. has a 1-year low of $51.66 and a 1-year high of $73.85. The stock has a market cap of $3.34 billion, a PE ratio of 70.06, a P/E/G ratio of 2.14 and a beta of 1.02.
Several analysts recently commented on the company. Piper Sandler lowered their target price on Merit Medical Systems from $79.00 to $75.00 in a research report on Friday, February 25th. Barrington Research lowered their target price on Merit Medical Systems from $82.00 to $78.00 in a research report on Thursday, April 28th. StockNews.com upgraded Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, April 13th. Raymond James dropped their price objective on Merit Medical Systems from $73.00 to $72.00 and set an “outperform” rating on the stock in a research note on Friday, February 25th. Finally, TheStreet downgraded Merit Medical Systems from a “b-” rating to a “c+” rating in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $74.40.
Merit Medical Systems Profile (Get Rating)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.